← Back to Patent Explorer
US4355032A Expired / Lapsed US ⏱️ 0.0 years remaining

9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent

Assignee: Hoffmann La Roche Inc
•
Filing: 1981-05-21
•
Granted: 1982-10-19
•
Expires: 2001-05-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The compound 9-(1,3-dihydroxy-2-propoxymethyl)guanine and the pharmaceutically acceptable salts thereof are useful as antiviral agents.

Inventors

  • 👤 Julien P. Verheyden
  • 👤 John C. Martin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 14:14
CPC Classifications
C; C07; C07D; C07D473/00; C07D473/02; C07D473/18; A; A61; A61P; A61P31/00; A61P31/12; A61P31/20; A61P31/22; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 9 words
The compound 9-(1,3-dihydroxy-2-propoxymethyl)guanine and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 9 words
The compound 9-(1,3-dihydroxy-2-propoxymethyl)guanine and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 3 words
The compound 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
Claim 4
Dependent Claim 3 words
The compound 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
Claim 5
Dependent Claim 5 words
The sodium salt of 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
Claim 6
Dependent Claim 5 words
The sodium salt of 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
Claim 7
Dependent Claim 22 words
The antiviral pharmaceutical composition which comprises a pharmaceutically acceptable carrier and an effective amount of 9-(1,3-dihydroxy-2-propoxymethyl)guanine or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 22 words
The antiviral pharmaceutical composition which comprises a pharmaceutically acceptable carrier and an effective amount of 9-(1,3-dihydroxy-2-propoxymethyl)guanine or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 35 words
Method of treating viral infections in a mammal having a viral infection which comprises administering an effective amount of 9-(1,3-dihydroxy-2-propoxymethyl)guanine or a pharmaceutically acceptable salt thereof or a composition containing same as an active ingredient.
Claim 10
Dependent Claim 35 words
Method of treating viral infections in a mammal having a viral infection which comprises administering an effective amount of 9-(1,3-dihydroxy-2-propoxymethyl)guanine or a pharmaceutically acceptable salt thereof or a composition containing same as an active ingredient.

References Cited (Backward Citations)

US4199574A Cited
US4294831A Cited
US4060616A Cited
US4221910A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-10-18 1986-04-19 1986-10-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-10-18 1990-04-19 1990-10-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-10-18 1994-04-19 1994-10-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag